Wave Life Sciences [WVE] vs Vera Therapeutics [VERA] Detailed Stock Comparison

Wave Life Sciences

NASDAQ
Loading...

Vera Therapeutics

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Wave Life Sciences wins in 7 metrics, Vera Therapeutics wins in 8 metrics, with 0 ties. Vera Therapeutics appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricWave Life SciencesVera TherapeuticsBetter
P/E Ratio (TTM)-10.21-10.96Vera Therapeutics
Price-to-Book Ratio7.994.11Vera Therapeutics
Debt-to-Equity Ratio14.7616.56Wave Life Sciences
PEG Ratio-0.43-0.12Wave Life Sciences
EV/EBITDA-6.85-6.13Wave Life Sciences
Profit Margin (TTM)-138.24%0.00%Vera Therapeutics
Operating Margin (TTM)-606.50%0.00%Vera Therapeutics
Return on Equity-171.41%-54.84%Vera Therapeutics
Return on Assets (TTM)-38.90%-30.24%Vera Therapeutics
Free Cash Flow (TTM)$-151.96M$-135.65MVera Therapeutics
1-Year Return-16.14%-27.57%Wave Life Sciences
Price-to-Sales Ratio (TTM)12.12N/AN/A
Enterprise Value$958.96M$1.44BVera Therapeutics
EV/Revenue Ratio10.21N/AN/A
Revenue per Share (TTM)$1$0Wave Life Sciences
Earnings per Share (Diluted)$-0.80$-3.59Wave Life Sciences
Beta (Stock Volatility)-1.371.23Wave Life Sciences
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Wave Life Sciences vs Vera Therapeutics Stock Performance Analysis

Loading Price Chart...

Wave Life Sciences
Vera Therapeutics
Wave Life Sciences Stock Overview | Vera Therapeutics Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Wave Life Sciences0.98%1.26%-4.75%2.27%24.48%-45.80%
Vera Therapeutics2.65%7.06%25.01%34.70%55.17%-26.68%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Wave Life Sciences-16.14%38.85%-19.06%-54.59%-54.59%-54.59%
Vera Therapeutics-27.57%61.31%169.04%169.04%169.04%169.04%

News Based Sentiment: Wave Life Sciences vs Vera Therapeutics

Wave Life Sciences

News based Sentiment: POSITIVE

October was a strong month for Wave Life Sciences, with a stock price increase, a significant investment from Platinum Investment Management, and overwhelmingly positive analyst ratings. These developments collectively signal growing confidence in the company's potential and future prospects, making it a noteworthy month for investors.

View Wave Life Sciences News Sentiment Analysis

Vera Therapeutics

News based Sentiment: MIXED

October was a month of contrasts for Vera Therapeutics, with significant institutional investment offset by a disappointing earnings report. While analyst sentiment remains generally positive, the earnings miss introduces uncertainty and necessitates a cautious outlook. The combination of these factors makes this a noteworthy month for investors.

View Vera Therapeutics News Sentiment Analysis

Performance & Financial Health Analysis: Wave Life Sciences vs Vera Therapeutics

MetricWVEVERA
Market Information
Market Cap i$1.15B$1.98B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,815,7401,529,620
90 Day Avg. Volume i2,178,9871,741,295
Last Close$7.22$30.94
52 Week Range$5.28 - $16.74$18.53 - $51.61
% from 52W High-56.87%-40.05%
All-Time High$56.00 (Sep 24, 2018)$51.61 (Nov 11, 2024)
% from All-Time High-87.11%-40.05%
Growth Metrics
Quarterly Revenue Growth-0.56%N/A
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i-1.38%0.00%
Operating Margin (TTM) i-6.07%0.00%
Return on Equity (TTM) i-1.71%-0.55%
Debt to Equity (MRQ) i14.7616.56
Cash & Liquidity
Book Value per Share (MRQ)$0.90$7.34
Cash per Share (MRQ)$1.31$8.72
Operating Cash Flow (TTM) i$-199,176,992$-185,271,008
Levered Free Cash Flow (TTM) i$-147,686,368$-111,946,496
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Wave Life Sciences vs Vera Therapeutics

MetricWVEVERA
Price Ratios
P/E Ratio (TTM) i-10.21-10.96
Forward P/E i-7.30-9.69
PEG Ratio i-0.43-0.12
Price to Sales (TTM) i12.12N/A
Price to Book (MRQ) i7.994.11
Market Capitalization
Market Capitalization i$1.15B$1.98B
Enterprise Value i$958.96M$1.44B
Enterprise Value Metrics
Enterprise to Revenue i10.21N/A
Enterprise to EBITDA i-6.85-6.13
Risk & Other Metrics
Beta i-1.371.23
Book Value per Share (MRQ) i$0.90$7.34

Financial Statements Comparison: Wave Life Sciences vs Vera Therapeutics

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)WVEVERA
Revenue/Sales i$9.18M$0
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development i$40.62M$41.28M
Operating Income (EBIT) i$-49.80M$-57.19M
EBITDA i$-47.64M$-49.82M
Pre-Tax Income i$-46.88M$-51.69M
Income Tax i$0N/A
Net Income (Profit) i$-46.88M$-51.69M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)WVEVERA
Cash & Equivalents i$243.08M$55.09M
Total Current Assets i$257.98M$606.08M
Total Current Liabilities i$87.37M$21.89M
Long-Term Debt i$15.72M$53.27M
Total Shareholders Equity i$171.80M$535.00M
Retained Earnings i$-1.17B$-512.94M
Property, Plant & Equipment i$73.17M$1.06M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)WVEVERA
Operating Cash Flow i$-51.25M$-41.22M
Capital Expenditures i$-165,000$-187,000
Free Cash Flow i$-63.20M$-54.59M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricWVEVERA
Shares Short i18.04M9.36M
Short Ratio i7.744.91
Short % of Float i0.15%0.17%
Average Daily Volume (10 Day) i1,815,7401,529,620
Average Daily Volume (90 Day) i2,178,9871,741,295
Shares Outstanding i153.04M63.56M
Float Shares i65.60M44.83M
% Held by Insiders i0.16%0.01%
% Held by Institutions i0.87%1.10%

Dividend Analysis & Yield Comparison: Wave Life Sciences vs Vera Therapeutics

MetricWVEVERA
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A